Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy: A Multicenter Prospective Observational Study

Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy: A Multicenter Prospective Observational Study

Background: Although antithrombotic agents are widely used for cardiac and cerebrovascular disease prevention, they increase the risk of gastrointestinal (GI) bleeding. Objective: To examine GI bleeding risk in association with an esophagogastroduodenoscopy (EGD) biopsy performed in patients without...

Full description

Bibliographic Details
Main Authors: Takafumi Yuki, MD, PhD, Shunji Ishihara, MD, PhD, Kazuo Yashima, MD, PhD, Koichiro Kawaguchi, MD, PhD, Hirofumi Fujishiro, MD, PhD, Youichi Miyaoka, MD, PhD, Mika Yuki, MD, PhD, Yoshinori Kushiyama, MD, PhD, Akiko Yasugi, MD, PhD, Michiko Shabana, MD, PhD, Koichirou Furuta, MD, PhD, Kiwamu Tanaka, MD, PhD, Masaharu Koda, MD, PhD, Tetsuro Hamamoto, MD, PhD, Yuichiro Sasaki, MD, PhD, Hisao Tanaka, MD, PhD, Teiji Yoshimura, MD, Yoshikazu Murawaki, MD, PhD, Hajime Isomoto, MD, PhD, Yoshikazu Kinoshita, MD, PhD
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Current Therapeutic Research
Subjects:
antiplatelet drug
anticoagulant drug
esophagogastroduodenoscopy
biopsy
gastrointestinal bleeding
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X16301230

Internet

http://www.sciencedirect.com/science/article/pii/S0011393X16301230

Similar Items